Jun. 1 at 3:53 PM
$ATLX CapEx and Expenditures summary from the PowerPoint on the ATLX website/investors - Corporate Presentation.
Total CapEX is only
$57.6MM. For a spodumene project, that is very small compared to many competitors, which is why Atlas has been emphasizing the modular DMS plant approach and startup strategy.
For every 1 tonne of 5.5% spodumene concentrate they sell, they estimate spending
$488.50 in operating costs. That's roughly an 80% operating margin, at today's spodumene prices (~2500$ / tonne), before taxes and royalties.
They believe they can produce 140,000 Tonnes / year with the current DMS plant.
$350 million in revenue,
$280 million operating profit!
